Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single ‐centre randomised controlled study

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - August 3, 2018 Category: Endocrinology Authors: Niina Matikainen , Sanni S öderlund , Elias Björnson , Kirsi Pietiläinen , Antti Hakkarainen , Nina Lundbom , Marja‐Riitta Taskinen , Jan Borén Source Type: research